NOVOFARMA, OOO, Moscow Oblast

Economic indicators

Net loss (RA) of NOVOFARMA, OOO made up 43.00 thousand RUB over 2024 compared to net profit of 9.00 thousand RUB over 2023, the company informed.

Revenue decreased in the accounting period ? times to 0.00 thousand RUB from 14.48 million RUB in 2023; cost of goods sold decreased 2,008.43 times to 7.00 thousand RUB from 14.06 million RUB; sales loss made up 7.00 thousand RUB compared to sales profit of 386.00 thousand RUB.

Net profit (RAS) of NOVOFARMA, OOO dropped in 2023 340.00 times to 9.00 thousand RUB from 3.06 million RUB over the same period in 2022, the company informed.

Revenue decreased in the accounting period 5.91 times to 14.48 million RUB from 85.60 million RUB in 2022; cost of goods sold decreased 5.71 times to 14.06 million RUB from 80.29 million RUB; sales profit fell 13.24 times to 386.00 thousand RUB from 5.11 million RUB.

Net profit (RAS) of NOVOFARMA, OOO grew over 2022 11.13 times to 3.06 million RUB from 275.00 thousand RUB over 2021, the company informed.

Revenue increased in the accounting period by 49.12% to 85.60 million RUB from 57.40 million RUB over 2021; cost of goods sold grew by 45.15% to 80.29 million RUB from 55.31 million RUB; sales profit went up 2.74 times to 5.11 million RUB from 1.87 million RUB.

Net profit (RAS) of NOVOFARMA, OOO made up 275.00 thousand RUB over 2021 compared to net loss of 721.00 thousand RUB over 2020, the company informed.

Revenue increased in the accounting period 5.66 times to 57.40 million RUB from 10.14 million RUB over 2020; cost of goods sold grew 6.10 times to 55.31 million RUB from 9.06 million RUB; sales profit made up 1.87 million RUB compared to sales loss of 476.00 thousand RUB.

Companies in the region

• KINGSTON PLAZA
• LAD'YA
• LILANI+
• RLTS SEVERNYY
• AVANGARD